The purpose of this study is: 1) to compare efficacy of Lamivudine vs. placebo in children with chronic hepatitis B (loss of HBeAg and HBV DNA from serum) and sustained normaliztion of ALT levels by week 52. 2) to compare safety of Lamivudine vs. placebo.
Showing the most recent 10 out of 782 publications